Form 4 for CVS CVS Health
Accepted 2023-05-19 00:00:00 ET · period of report 2023-05-18 · accession 0001127602-23-016333 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-18 | CVS | Finucane Anne A. | Dir | A - Grant | $69.31 | +1,437 | 8,757 | +20% | +$99.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-18 | A | A | 1,437 | $69.31 | 8,757.25 | D | — | — |